Local view for "http://purl.org/linkedpolitics/eu/plenary/2013-10-22-Speech-2-397-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2013-10-22"^^xsd:date2
dcterms:Is Part Of	lp_eu:Patient safety (A7-0320/2013 - Oreste Rossi)2
dcterms:Language	"en"^^xsd:language2
lpv:document identification number	"en.20131022.34.2-397-000"2
lpv:hasSubsequent	lp_eu:2013-10-22-Speech-2-397-5002
lpv:speaker	lp:Kay Swinburne2
lpv:spoken text	"We have already considered reports today that address key issues relating to patient safety in the field of medical devices, so it is timely that we also have this opportunity to review, from a broader perspective, what can be done to improve patient safety within the EU. I am particularly pleased to see that this report is taking the opportunity to tackle the important issues surrounding the off-label use of medicines. Where alternative authorised treatments exist and are available to patients within the EU, we need to ensure robust guidelines for any off-label usage and take into account patient safety above any cost-cutting incentives."@en1
lpv:spokenAs	substitute; Delegation to the Parliamentary Assembly of the Union for the Mediterranean (2012-03-28--2014-06-30)3 substitute; CULT (2012-01-25--2014-06-30)3 substitute; Delegation for relations with Switzerland and Norway and to the EU-Iceland Joint Parliamentary Committee and the European Economic Area (EEA) Joint Parliamentary Committee (2009-09-16--2014-06-30)3 substitute; Delegation for relations with the Palestinian Legislative Council (2009-10-19--2014-06-30)3 member; ECON (2012-01-19--2014-06-30)3 unknown; Conservative Party (2009-07-14--2014-06-30)3 member; PECH (2009-07-14--2014-06-30)3
lpv:unclassifiedMetadata	"Kay Swinburne (ECR ),"1 "in writing"1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph